Xbrane Biopharma AB (publ) (STO:XBRANE)
Sweden · Delayed Price · Currency is SEK 7.44
+0.14 (1.92%)
Apr 10, 2026, 5:29 PM CET
Xbrane Biopharma AB Market Cap
Xbrane Biopharma AB has a market cap or net worth of 150.42 million as of April 10, 2026. Its market cap has decreased by -53.69% in one year.
Market Cap
150.42M
Enterprise Value
122.14M
Revenue
152.35M
Ranking
n/a
PE Ratio
1.18
Stock Price
7.44
Market Cap Chart
Since February 3, 2016, Xbrane Biopharma AB's market cap has increased from 131.05M to 150.42M, an increase of 14.78%. That is a compound annual growth rate of 1.36%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 150.42M | -28.43% |
| Dec 30, 2025 | 210.17M | -14.54% |
| Dec 30, 2024 | 245.94M | -17.28% |
| Dec 29, 2023 | 297.31M | -86.83% |
| Dec 30, 2022 | 2.26B | -13.94% |
| Dec 30, 2021 | 2.62B | 58.03% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Isofol Medical AB | 182.72M |
| AlzeCure Pharma AB | 171.22M |
| Active Biotech AB | 166.07M |
| NextCell Pharma AB | 145.03M |
| IRLAB Therapeutics AB | 134.20M |
| Simris Group AB (PUBL) | 115.81M |
| Alligator Bioscience AB | 107.91M |
| Biovica International AB | 105.09M |